Epilepsy Clinical Trials in New York, New York

9 studies are recruiting for epilepsy in New York, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. SeizEAR Safety Study

   Determine the safety and feasibility of an in-ear device to measure seizures or suspected seizures compared to the standard scalp-based electroencephalogram (EEG). The study team anticipates enrolling five healthy participants through meeting announcements and a research email list serv in the Neur…

   Stage

   Not phased

   Ages

   18 to 70

   Site

   Icahn School of Medicine at Mount Sinai, New York, New York

   Run by

   Icahn School of Medicine at Mount Sinai

   See if you can join NCT07088835 on ClinicalTrials.gov

2. Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures

   This is a clinical research study for an investigational drug called RAP-219 in adult participants with focal seizures. This study is being conducted to determine if RAP-219 is safe and effective in reducing focal seizure frequency.

   Stage

   Phase 3

   Ages

   18 to 75

   Site

   Lenox Hill Hospital, New York, New York

   Locations

   11 in total

   Run by

   Rapport Therapeutics Inc.

   See if you can join NCT07594119 on ClinicalTrials.gov

3. Hippocampal Oscillations During Exploration

   The objective of this study is to determine how visuomotor exploration relates to hippocampal activity along its long axis. The study will investigate the neurophysiological mechanisms in the hippocampus during (1) visual exploration in surgical patients using high-resolution iEEG, and (2) ambulato…

   Stage

   Not phased

   Ages

   18 to 70

   Site

   NYU Langone Health, New York, New York

   Run by

   NYU Langone Health

   See if you can join NCT07224191 on ClinicalTrials.gov

4. Brain Metabolism Observed at 3 Tesla or 7 Tesla in Health and Metabolic Disease

   The goal is to develop methodology to monitor flux in the citric acid cycle in brain via 13C nuclear magnetic resonance (NMR) spectroscopy at 7 Tesla or 3 Tesla.

   Stage

   Not phased

   Ages

   16 to 80

   Site

   Weill Cornell Medicine, New York, New York

   Locations

   2 in total

   Run by

   Weill Medical College of Cornell University

   See if you can join NCT05085704 on ClinicalTrials.gov

5. NYU Epilepsy Self-Management Study

   The investigators will conduct two-arm randomized controlled trials (RCTs) comparing effects of UPLIFT vs. enhanced usual care and PACES vs. enhanced usual care, respectively, on quality of life, depressive symptoms and seizures over 12 months in NYU patients with epilepsy.

   Stage

   Not phased

   Ages

   18 and older

   Site

   NYU Langone Health - NYU Comprehensive Epilepsy Center, New York, New York

   Locations

   2 in total

   Run by

   NYU Langone Health

   See if you can join NCT07087821 on ClinicalTrials.gov

6. Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits

   Methylphenidate (MPH) is a stimulant, FDA-approved for the treatment of attention deficit hyperactivity disorder (ADHD). It is unknown, however, if stimulants would be of benefit for memory and thinking problems due to epilepsy. In this study, participants will be assigned randomly (i.e., by flip o…

   Stage

   Phase 4

   Ages

   18 and older

   Site

   VA NY Harbor Healthcare System, New York, NY, New York, New York

   Locations

   4 in total

   Run by

   VA Office of Research and Development

   See if you can join NCT04419272 on ClinicalTrials.gov

7. Telephone-Based Support Programs for People With Epilepsy

   This is a two-arm randomized controlled trial to compare telephone-based depression self-management (UPLIFT) to telephone-based support groups (BOOST). A sample of 120 English- and Spanish-speaking people with epilepsy (PWE) with elevated depressive symptoms will be enrolled. Both interventions are…

   Stage

   Not phased

   Ages

   18 to 99

   Site

   NYU Langone Health, New York, New York

   Run by

   NYU Langone Health

   See if you can join NCT05082181 on ClinicalTrials.gov

8. Prediction of Anxiety and Memory State

   The purpose of this study is to look at how signals in the brain, body, and behavior relate to anxiety and memory function. This project seeks to develop the CAMERA (Context-Aware Multimodal Ecological Research and Assessment) platform, a state-of-the-art open multimodal hardware/software system fo…

   Stage

   Not phased

   Ages

   18 to 55

   Site

   Columbia University Irving Medical Center, New York, New York

   Run by

   Columbia University

   See if you can join NCT06551090 on ClinicalTrials.gov

9. A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures

   This is a clinical research study for an investigational drug called RAP-219 in patients with Refractory Focal Epilepsy. This study is being conducted to determine RAP-219 Long- term safety and open-label antiseizure activity in patients with Refractory Focal Epilepsy.

   Stage

   Phase 2

   Ages

   18 to 70

   Site

   NYU Langone Comprehensive Epilepsy Center, New York, New York

   Locations

   7 in total

   Run by

   Rapport Therapeutics Inc.

   See if you can join NCT07219407 on ClinicalTrials.gov